Back to search

Article

Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance

2019-05-31

Abstract excerpt

Resistance to systemic drug therapies is a major reason for the failure of anti-cancer therapies. Here, we tested doxorubicin-loaded human serum albumin (HSA) nanoparticles in the neuroblastoma cell line UKF-NB-3 and its ABCB1-expressing sublines adapted to vincristine (UKF-NB-3 r VCR 1 ) and doxorubicin (UKF-NB-3 r DOX 20 ). Doxorubicin-loaded nanoparticles displayed increased anti-cancer activity in UKF-NB-3...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
61b16bb6-bf08-5ef2-ad88-bf673d752bd8
DOI
10.1101/655662
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistanceDOI 10.1101/655662
Select a neighboring publication to make it the new centre.